Clinical Trial

Mitigating Inhaled Wood Smoke Inflammation

Study Description

A Study of Gamma Tocopherol-enriched Supplement on Lower Airway Responses to Inhaled Wood Smoke in Healthy Adults

Purpose: To determine the efficacy of 1400 mg gamma tocopherol-enriched supplement for mitigating inhaled wood smoke particle-induced airway inflammation in healthy adults with no more than mild asthma.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Gamma Tocopherol

Each dose consists of two (700 mg) capsules by mouth once daily for a total of 7 days.

Drug - Placebo

Each dose consists of two (700 mg) capsules by mouth once daily for a total of 7 days.

Additional Information

Official Study Title

A Phase II Randomized, Double Blinded, Placebo-controlled Study of Gamma Tocopherol-enriched Supplement on Lower Airway Responses to Inhaled Wood Smoke in Healthy Adults

Clinical Trial ID

NCT03444298

ParticipAid ID

rb2YWa